(Q42646672)

4 November 2017

Hepatitis C in methadone maintenance patients: prevalence and public policy implications (English)

1 reference

4 November 2017

1 reference

McCarthy JJ

1

1 reference

PubMed ID

11286428

4 November 2017

Flynn N

series ordinal

2

1 reference

4 November 2017

1 January 2001

1 reference

Journal of Addictive Diseases

4 November 2017

1 reference

4 November 2017

20

1 reference

4 November 2017

1

1 reference

4 November 2017

19-31

1 reference

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

4 November 2017

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Epidemiology of hepatitis C in the West

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Infrequent vertical transmission of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Seroprevalence of hepatitis A, B, C, and D markers and liver function abnormalities in intravenous heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Immunologic and viral markers in the circulation of anti-HIV negative heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Viral hepatitis and drugs: a continuing problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

The pro-heroin effects of anti-opium laws in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

HIV infection among injecting drug users in Asia: an evolving public health crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

Medical maintenance: the treatment of chronic opiate dependence in general medical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_03

21 January 2018

Identifiers

DOI

10.1300/J069V20N01_03

1 reference

4 November 2017

1 reference

PubMed ID

11286428